Why the pharmaceutical industry has ‘mixed views’ on Biden’s latest executive order
(By Katie Adams for Becker’s Hospital Review) The American Pharmacists Association “has mixed views” on the executive order President Joe
Read More(By Katie Adams for Becker’s Hospital Review) The American Pharmacists Association “has mixed views” on the executive order President Joe
Read More(By Michael McAuliff for Kaiser Health News) The largest drug companies are far more interested in enriching themselves and investors
Read More(By Nick Moran for Becker’s Hospital Review) A coalition of payers and healthcare providers publicly voiced their support for a
Read More(By Nick Moran for Becker’s Hospital Review) Rep. Pramila Jayapal, D-Wash., said the White House is supportive of proposals for sweeping
Read More(By Nick Moran for Becker’s Hospital Review) Democratic representatives reintroduced the Medicare Vision Act of 2021 June 28 in an
Read More(By Katheryn Houghton for Kaiser Health News) Under pressure to rein in skyrocketing prescription drug costs, states are targeting companies
Read More(By Lauren Jensik for Becker’s Hospital Review) Nevada Gov. Steve Sisolak signed a bill making the state’s managed health insurance program
Read More(By Morgan Haefner for Becker’s Hospital Review) A new law in Louisiana will bar health insurers from implementing a pharmacy
Read MoreThe House passed the Fairness in Orphan Drug Exclusivity Act (H.R. 1629) to fix the nation’s orphan drug development rules
Read More(By Morgan Haefner for Becker’s Hospital Review) House Democrats issued a request for information May 26 to create a public option
Read More